Hypothetical $10,000 invested at their first disclosed trade date. · log scale
Hypothetical backtest based on disclosed trades. Past performance does not predict future results. Not investment advice.
| Ticker | Action | Description | Traded |
|---|---|---|---|
| OTHER | Buy | — | Nov 16, 2021 |
| WBA | Sell | Wabtec | Apr 26, 2019 |
| WAB | Sell | Wabtec | Apr 26, 2019 |
| DNB | Sell | Dun & Bradstreet | Feb 8, 2019 |
| OTHER | Sell | Cigna Corporation | Dec 21, 2018 |
| OTHER | Sell | Cigna Corporation | Dec 21, 2018 |
| MON | Sell | Monsanto Company | Jun 17, 2018 |
| OTHER | Buy | — | Nov 16, 2017 |
| AET | Buy | AETNA INC | Sep 8, 2016 |
| AET | Sell | AETNA INC | Sep 8, 2016 |
Jim Sensenbrenner is a United States Representative from WI affiliated with the Republican Party, serving in the US House of Representatives. Disclosed Capitol tracks 25 disclosed stock trades from Jim Sensenbrenner, filed under the STOCK Act. The portfolio compounds at 26.9% annualized — 2.8% below the S&P 500 benchmark over the same period, with a 33% win rate on individual trades. The full trade history, holdings, sector allocation, and risk metrics are below.
Jim Sensenbrenner (R-WI) has disclosed 25 trades under the STOCK Act; portfolio CAGR of 26.9% (-2.8% vs. the S&P 500); top tickers traded: N/A, AET, WBA.
Full trade list with transaction dates, disclosure dates, tickers, and amount ranges is in the interactive table below.
Most-traded tickers: N/A, AET, WBA. Sector allocation and portfolio weighting appear in the Holdings panel.
Annualized return: 26.9% CAGR, -2.8% alpha vs. the S&P 500. Detailed performance charts are in the Performance panel.